Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Induced Pluripotent Stem Cell (Ips Cell)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02836145
What this trial is testing

Biomolecular Messages Associated With the Differentiation of Human Induced Pluripotent Stem Cells to Skeletal Muscle Progenitor Cells

Who this might be right for
Female Urinary Incontinence and Pelvic Organ Prolapse
National Taiwan University Hospital 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06825169
What this trial is testing

A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)
Nuwacell Biotechnologies Co., Ltd. 30
Very early researchNot Yet RecruitingNCT06702098
What this trial is testing

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangzhou Ruixin Biotechnological Co., LTD 10
Not applicableActive Not RecruitingNCT03199300
What this trial is testing

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

Who this might be right for
Toxicity Due to ChemotherapyCardiovascular MorbidityCancer, Treatment-Related
University Medical Center Groningen 20
Not applicableEnrolling By InvitationNCT01517425
What this trial is testing

Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells

Who this might be right for
Coronary Artery Disease
Scripps Translational Science Institute 200
Not applicableNot Yet RecruitingNCT05991986
What this trial is testing

Preparation of Patient Autologous Induced Pluripotent Stem Cell-derived Retinal Cells for AMD

Who this might be right for
Age-Related Macular Degeneration
Zhongshan Ophthalmic Center, Sun Yat-sen University 10
Not applicableUnknownNCT04122742
What this trial is testing

Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.

Who this might be right for
Rubinstein-Taybi Syndrome
University Hospital, Bordeaux 154
Not applicableStudy completedNCT02193724
What this trial is testing

Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma

Who this might be right for
Retinoblastoma
St. Jude Children's Research Hospital 15
Early research (Phase 1)Looking for participantsNCT06978920
What this trial is testing

A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease

Who this might be right for
Parkinson Disease
Nuwacell Biotechnologies Co., Ltd. 48
Not applicableStudy completedNCT01860898
What this trial is testing

A Phase I Study of iPS Cell Generation From Patients With COPD

Who this might be right for
Thoracic DiseasesRespiratory Tract DiseasesCancer of Lung+11 more
Mayo Clinic 31
Not applicableActive Not RecruitingNCT03025763
What this trial is testing

Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones

Who this might be right for
Craniosynostosis
Icahn School of Medicine at Mount Sinai 2,145
Not applicableEnded earlyNCT01734356
What this trial is testing

Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells

Who this might be right for
Inherited Arrhythmias and Valvulopathies
Nantes University Hospital 20
Not applicableLooking for participantsNCT01143454
What this trial is testing

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Who this might be right for
Metabolic DiseaseObesityLi-Fraumeni Syndrome+3 more
National Heart, Lung, and Blood Institute (NHLBI) 5,000
Not applicableLooking for participantsNCT01432847
What this trial is testing

Cell Collection to Study Eye Diseases

Who this might be right for
Retinal DiseaseAMDRetinal Degeneration+1 more
National Eye Institute (NEI) 930
Not applicableStudy completedNCT03867526
What this trial is testing

Establishment of Human Cellular Disease Models for Wilson Disease

Who this might be right for
Wilson Disease
CENTOGENE GmbH Rostock 40
Early research (Phase 1)Ended earlyNCT05336409
What this trial is testing

CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Who this might be right for
R/R CD19-Positive B-Cell MalignanciesIndolent Non-Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma
Century Therapeutics, Inc. 28
Not applicableStudy completedNCT05616338
What this trial is testing

Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)

Who this might be right for
Severe AsthmaAllergic Bronchopulmonary Aspergillosis (ABPA)
University Hospital, Montpellier 4
Not applicableStudy completedNCT02464956
What this trial is testing

Production of iPSC Derived RPE Cells for Transplantation in AMD

Who this might be right for
Age Related Macular Degeneration (AMD)
Moorfields Eye Hospital NHS Foundation Trust 3
Early research (Phase 1)Not Yet RecruitingNCT07617012
What this trial is testing

The Safety, Tolerability, and Efficacy of Dopaminergic Neural Progenitor Cells (XS411CN Cell Injection) for the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P).

Who this might be right for
the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. 3
Not applicableUnknownNCT02417311
What this trial is testing

Individualized Early Risk Assessment for Heart Diseases

Who this might be right for
Cardiomyopathy, HypertrophicCardiomyopathy, Dilated
Universitätsklinikum Hamburg-Eppendorf 80
Next Page